Myia Health Names Former Blue Cross Blue Shield MN CEO Craig Samitt Executive Chairman
Samitt brings years of health plan and health system experience to the virtual healthcare delivery platformSAN FRANCISCO, July 21, 2022...
Day: July 21, 2022
AXIM Biotechnologies Celebrates Feature on the Vision is More Than 20/20™ Podcast
SAN DIEGO, July 21, 2022 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM Biotech,” “AXIM” or “the Company”), an...
XIL Health Ranks No. 35 in the 2022 Top 50 Inspiring Workplaces in North America Award
The St. Louis-based healthtech company offers benefits like paid parental leave, profit sharing and mental health daysST. LOUIS, July 21,...
22nd Century Announces $35 Million Registered Direct Offering Priced Above Market under Nasdaq Rules
BUFFALO, N.Y., July 21, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), leading agricultural biotechnology company dedicated to improving...
Nanomix Announces Distribution Agreement for the eLab System with Biotron Ltd. in Israel
SAN LEANDRO, Calif., July 21, 2022 (GLOBE NEWSWIRE) -- Nanomix Corporation (OTCQB: NNMX) (“Nanomix” or the “Company”), a leader in...
Better Choice Company to Host Second Quarter 2022 Earnings Call on August 11th at 8:30 a.m. ET
NEW YORK, July 21, 2022 (GLOBE NEWSWIRE) -- Better Choice Company (NYSE: BTTR) (“Better Choice” or “the Company”), a pet...
Healthy Directions Instaflex Provides Pain Relief During the Summer Heat
Instaflex Pain Relief Cream The Instaflex formula combines essential oxygenated oil with menthol to provide fast, targeted relief. Because it...
ReWalk Receives Court Approval for Share Repurchase Program
MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel, July 21, 2022 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (the...
Achilles Therapeutics to lead Horizon Europe-Funded Consortium to Advance Personalized Cell Therapy Manufacturing
€4 million ($4.2 million) research and innovation award for consortium to develop first-in-class smart bioprocessing manufacturing platformLONDON, July 21, 2022...
OrthoPediatrics Corp. to Report Second Quarter 2022 Financial Results on August 4, 2022
WARSAW, Ind., July 21, 2022 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company focused exclusively on advancing the...
Collegium to Report Second Quarter 2022 Financial Results on August 4, 2022
STOUGHTON, Mass., July 21, 2022 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company, today...
Pliant Therapeutics Receives FDA Fast Track Designation for PLN-74809 for the Treatment of Primary Sclerosing Cholangitis
SOUTH SAN FRANCISCO, Calif., July 21, 2022 (GLOBE NEWSWIRE) -- Pliant Therapeutics (NASDAQ: PLRX) announced today that PLN-74809, its oral,...
Minerva Surgical Announces Appointment of Derrick Sung, Ph.D. to Board of Directors
SANTA CLARA, Calif., July 21, 2022 (GLOBE NEWSWIRE) -- Minerva Surgical, Inc. (Nasdaq: UTRS) (“Minerva Surgical” or the “Company”), a...
Cytek to Participate in the 42nd Annual Canaccord Genuity Global Growth Conference
FREMONT, Calif., July 21, 2022 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), today announced the...
Nemaura Medical Granted UK Trademark “Meta Score,” a Digital Biomarker Term for its Metabolic Health Program
Loughborough, England, July 21, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical technology...
DAXOR CORPORATION ANNOUNCES PARTNERSHIP WITH MEDAXIOM TO ADVANCE AWARENESS AND FURTHER ADOPTION OF DAXOR’S BLOOD VOLUME DIAGNOSTIC (BVA-100®)
Daxor Has Exclusive Access to the Cardiovascular Industry's Most Comprehensive and Powerful Network of Executives and Clinicians - Sharing Best...
180 Life Sciences Corp. Announces Closing of $6.5 Million Registered Direct Offering
PALO ALTO, Calif., July 21, 2022 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF, “180 Life Sciences” or the...
Celldex Announces First Patient Dosed in Phase 2 Study of Barzolvolimab in Patients with Chronic Inducible Urticaria
HAMPTON, N.J., July 21, 2022 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) today announced that the first patient has been...
Opus Genetics Expands its Leadership Team
Vikram Arora, Ph.D., DABT, appointed Vice President of Non-Clinical Development Erin O’Neil, M.D., appointed Vice President of Clinical Development Sarah...
Simply Better Brands Corp. PureKana Brand Performance Recognized for Outpacing the CBD Category
Brightfield Research Group Recognizes PureKana as one of the Fastest Growing CBD Brands to Start 2022 in Mid-year Industry ReportVANCOUVER,...